Correlation Between Douglas Emmett and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Douglas Emmett and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Douglas Emmett and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Douglas Emmett and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Douglas Emmett and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Douglas Emmett with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Douglas Emmett and Mineralys Therapeutics,.

Diversification Opportunities for Douglas Emmett and Mineralys Therapeutics,

0.43

Correlation Coefficient

Douglas Emmett  Mineralys Therapeutics,

Very weak diversification

The 3 months correlation between Douglas and Mineralys is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Douglas Emmett and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Douglas Emmett is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Douglas Emmett are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Douglas Emmett i.e., Douglas Emmett and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Douglas Emmett and Mineralys Therapeutics,

Considering the 90-day investment horizon Douglas Emmett is expected to generate 0.46 times more return on investment than Mineralys Therapeutics,. However, Douglas Emmett is 2.18 times less risky than Mineralys Therapeutics,. It trades about -0.02 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.11 per unit of risk. If you would invest  1,817  in Douglas Emmett on October 23, 2024 and sell it today you would lose (67.00) from holding Douglas Emmett or give up 3.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Douglas Emmett  vs.  Mineralys Therapeutics, Common

Douglas Emmett

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Douglas Emmett has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical and fundamental indicators, Douglas Emmett is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Douglas Emmett and Mineralys Therapeutics,

The main advantage of trading using opposite Douglas Emmett and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Douglas Emmett position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Douglas Emmett and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .